EMA - Reflection paper on the use of artificial intelligence in the lifecycle of medicines

20th July 2023

EMA - Reflection paper on the use of artificial intelligence in the lifecycle of medicines 

EMA has published a draft reflection paper outlining the current thinking on the use of artificial intelligence (AI) to support the safe and effective development, regulation and use of human and veterinary medicines. This paper, which is now open for public consultation, reflects on principles relevant to the application of AI and machine learning (ML) at any step of a medicines’ lifecycle, from drug discovery to the post-authorisation setting.

Read Now

Back to News Archive